Percutaneous revascularization of chronic total occlusions: Rationale, indications, techniques, and the cardiac

Lorenzo Azzalini1, Gianluca Torregrossa2, John D Puskas2

  • 1Division of Interventional Cardiology, Cardio-Thoracic-Vascular Department, San Raffaele Scientific Institute, Milan, Italy.

Insights

Chronic total occlusion (CTO) revascularization is undertreated but offers improved outcomes. Modern techniques achieve high success rates for CTO treatment, enhancing patient survival and quality of life.

Area of Science:

  • Cardiology
  • Interventional Cardiology

Background:

  • Chronic total occlusions (CTOs) are common and often lead to incomplete revascularization, associated with poorer long-term outcomes, including mortality.
  • Despite clinical indications, CTO revascularization is undertreated due to misconceptions about benefits and historical challenges with percutaneous coronary intervention (PCI).

Purpose of the Study:

  • To critically appraise the literature supporting the rationale, indications, and techniques for revascularizing chronic total occlusions (CTOs).
  • To highlight advancements in percutaneous and surgical approaches for CTO treatment.

Main Methods:

  • Review of current literature on chronic total occlusion (CTO) revascularization.
  • Analysis of percutaneous coronary intervention (PCI) and surgical revascularization techniques and outcomes.

Main Results:

  • Modern percutaneous techniques achieve success rates of approximately 90% for CTO revascularization.
  • State-of-the-art surgical techniques provide complete revascularization with excellent long-term patency.

Conclusions:

  • CTO revascularization is feasible and beneficial, challenging previous misconceptions.
  • Advancements in both percutaneous and surgical interventions have significantly improved success rates and outcomes for patients with CTOs.

Related Concept Videos

Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
472
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
357
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
1.5K
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
568
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
432